Charmacy Pharmaceutical Temettü
Temettü kriter kontrolleri 2/6
Charmacy Pharmaceutical is a dividend paying company with a current yield of 3.65% that is well covered by earnings.
Anahtar bilgiler
3.7%
Temettü verimi
n/a
Geri Alım Getirisi
| Toplam Hissedar Getirisi | n/a |
| Gelecekteki Temettü Verimi | n/a |
| Temettü Büyümesi | -2.6% |
| Bir sonraki temettü ödeme tarihi | n/a |
| Eski temettü tarihi | n/a |
| Hisse başına temettü | HK$0.324 |
| Ödeme oranı | 63% |
Son temettü güncellemeleri
Recent updates
There Could Be A Chance Charmacy Pharmaceutical Co., Ltd.'s (HKG:2289) CEO Will Have Their Compensation Increased
May 13
There's Reason For Concern Over Charmacy Pharmaceutical Co., Ltd.'s (HKG:2289) Massive 40% Price Jump
Apr 24Charmacy Pharmaceutical Co., Ltd. (HKG:2289) Stock's 26% Dive Might Signal An Opportunity But It Requires Some Scrutiny
Jan 19These 4 Measures Indicate That Charmacy Pharmaceutical (HKG:2289) Is Using Debt Reasonably Well
Oct 25If EPS Growth Is Important To You, Charmacy Pharmaceutical (HKG:2289) Presents An Opportunity
Sep 17Is Charmacy Pharmaceutical (HKG:2289) A Risky Investment?
May 02What Type Of Returns Would Charmacy Pharmaceutical's(HKG:2289) Shareholders Have Earned If They Purchased Their SharesThree Years Ago?
Mar 15Are Dividend Investors Making A Mistake With Charmacy Pharmaceutical Co., Ltd. (HKG:2289)?
Feb 17We Wouldn't Rely On Charmacy Pharmaceutical's (HKG:2289) Statutory Earnings As A Guide
Jan 27Returns On Capital At Charmacy Pharmaceutical (HKG:2289) Paint An Interesting Picture
Jan 09What Charmacy Pharmaceutical Co., Ltd.'s (HKG:2289) ROE Can Tell Us
Dec 22
Reflecting on Charmacy Pharmaceutical's (HKG:2289) Share Price Returns Over The Last Three Years
Nov 29Ödemelerde İstikrar ve Büyüme
Temettü verilerini getirme
İstikrarlı Temettü: 2289 has been paying a dividend for less than 10 years and during this time payments have been volatile.
Büyüyen Temettü: 2289 has only been paying a dividend for 8 years, and since then payments have fallen.
Piyasaya Karşı Temettü Getirisi
| Charmacy Pharmaceutical Piyasaya Karşı Temettü Getirisi |
|---|
| Segment | Temettü Verimi |
|---|---|
| Şirket (2289) | 3.7% |
| Pazarın Alt %25'i (HK) | 3.2% |
| Pazarın En İyi %25'i (HK) | 7.9% |
| Sektör Ortalaması (Healthcare) | 4.1% |
| Analist tahmini (2289) (3 yıla kadar) | n/a |
Önemli Temettü: 2289's dividend (3.65%) is higher than the bottom 25% of dividend payers in the Hong Kong market (3.25%).
Yüksek Temettü: 2289's dividend (3.65%) is low compared to the top 25% of dividend payers in the Hong Kong market (7.92%).
Hissedarlara Ödenen Kazanç
Kazanç Kapsamı: With its reasonable payout ratio (62.6%), 2289's dividend payments are covered by earnings.
Hissedarlara Nakit Ödeme
Nakit Akışı Kapsamı: 2289 is paying a dividend but the company has no free cash flows.